BOUNDLESS BIO INC (BOLD) Stock Analyst Ratings
NASDAQ:BOLD - Nasdaq - US10170A1007 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to BOLD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 237.19% above the current price.
BOLD was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about BOLD.
In the last month the buy percentage rose by 32 points. So the trust of analysts is improving.
BOLD was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-02 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-28 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-12-13 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-04-22 | Leerink Partners | Initiate | Outperform |
| 2024-04-22 | Guggenheim | Initiate | Buy |
| 2024-04-22 | Piper Sandler | Initiate | Overweight |